US$ 21.53
glp 1 agonist ilaçlar Novo Nordisk GLP-1 Semaglutide Weight Loss Project Phase 2 Trial III Succeeded! - Industry news - News GLP-1 İlaçlar (Ozempic gibi) Nedir?
Description
Orforglipron is the first small molecule to act as an oral GLP-1 agonist"

Heart rate was elevated with RG7697/NNC0090-2746 (5.6 bpm relative to placebo), and 43% of individuals who received the co-agonist developed anti-drug antibodies, although these antibodies did not appear to alter drug efficacy

European Medicines Agency, 2022a

Choi JG, Winn AN, Skandari MR, et al

Safety and efficacy of oral semaglutide versus dulaglutide both in combination with one OAD (oral antidiabetic drug) in Japanese subjects with type 2 diabetes (PIONEER10)

Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials
